Total Payments
$9,938
2024 Payments
$763.66
Companies
61
Transactions
493
Medicare Patients
323
Medicare Billing
$23,290
Payment Breakdown by Category
Food & Beverage$7,993 (80.4%)
Travel$1,555 (15.6%)
Consulting$310.00 (3.1%)
Education$80.60 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,993 | 482 | 80.4% |
| Travel and Lodging | $1,555 | 4 | 15.6% |
| Consulting Fee | $310.00 | 5 | 3.1% |
| Education | $80.60 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intersect ENT, Inc. | $2,301 | 17 | $0 (2019) |
| ABBVIE INC. | $1,136 | 88 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $606.45 | 29 | $0 (2024) |
| AERIN MEDICAL INC. | $512.01 | 23 | $0 (2024) |
| PFIZER INC. | $354.23 | 45 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $341.49 | 13 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $298.01 | 11 | $0 (2024) |
| ITI, Inc. | $290.64 | 27 | $0 (2023) |
| Corium, LLC | $279.68 | 22 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $278.72 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $763.66 | 34 | AERIN MEDICAL INC. ($133.40) |
| 2023 | $2,994 | 202 | AbbVie Inc. ($434.76) |
| 2022 | $2,490 | 156 | ABBVIE INC. ($605.37) |
| 2021 | $845.76 | 50 | Otsuka America Pharmaceutical, Inc. ($141.57) |
| 2020 | $174.10 | 10 | Aerin Medical Inc. ($85.43) |
| 2019 | $243.63 | 7 | Intersect ENT, Inc. ($184.60) |
| 2018 | $354.27 | 14 | Intersect ENT, Inc. ($199.84) |
| 2017 | $2,073 | 20 | Intersect ENT, Inc. ($1,917) |
All Payment Transactions
493 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Respiratory | ||||||
| 12/06/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: EAR NOSE & THROAT | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: EAR NOSE & THROAT | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: IMMUNOLOGY | ||||||
| 07/24/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: EAR NOSE & THROAT | ||||||
| 07/23/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: Neurology | ||||||
| 06/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Immunology | ||||||
| 06/20/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Neurology | ||||||
| 06/10/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $54.95 | General |
| Category: Immunology | ||||||
| 05/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Immunology | ||||||
| 04/26/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: EAR NOSE & THROAT | ||||||
| 04/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Education | In-kind items and services | $25.65 | General |
| Category: NEUROSCIENCE | ||||||
| 04/02/2024 | Hologic Sales and Service, LLC | CoolSeal Generator (Device) | Food and Beverage | In-kind items and services | $31.76 | General |
| Category: Surgical | ||||||
| 03/27/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: IMMUNOLOGY | ||||||
| 02/19/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: EAR NOSE & THROAT | ||||||
| 02/12/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: PSYCHIATRY | ||||||
| 02/06/2024 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: PAIN | ||||||
| 02/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Obesity | ||||||
| 01/31/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 01/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Biological | ||||||
| 01/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: PSYCHIATRY | ||||||
| 01/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 120 | 155 | $18,347 | $8,175 |
| 2022 | 3 | 155 | 201 | $25,275 | $11,225 |
| 2021 | 2 | 48 | 56 | $6,686 | $3,890 |
Total Patients
323
Total Services
412
Medicare Billing
$23,290
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 103 | $11,124 | $5,534 | 49.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 41 | $6,519 | $2,267 | 34.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $704.00 | $374.04 | 53.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 101 | $16,059 | $7,343 | 45.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 65 | 82 | $8,856 | $3,710 | 41.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 15 | 18 | $360.00 | $172.58 | 47.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 37 | 45 | $4,860 | $2,509 | 51.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 11 | 11 | $1,826 | $1,380 | 75.6% |
About Dr. Christopher Rose, M.D
Dr. Christopher Rose, M.D is a Otolaryngology healthcare provider based in Leawood, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2011. The National Provider Identifier (NPI) number assigned to this provider is 1548550502.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Rose, M.D has received a total of $9,938 in payments from pharmaceutical and medical device companies, with $763.66 received in 2024. These payments were reported across 493 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($7,993).
As a Medicare-enrolled provider, Rose has provided services to 323 Medicare beneficiaries, totaling 412 services with total Medicare billing of $23,290. Data is available for 3 years (2021–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Otolaryngology
- Other Specialties Otolaryngology
- Location Leawood, KS
- Active Since 04/12/2011
- Last Updated 07/22/2025
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1548550502
Products in Payments
- PROPEL (Device) $1,827
- VRAYLAR (Drug) $450.21
- ABILIFY MAINTENA (Drug) $409.09
- UBRELVY (Drug) $355.01
- Kerendia (Drug) $341.49
- CAPLYTA (Drug) $305.93
- HETLIOZ (Drug) $277.83
- VIVAER STYLUS (Device) $229.05
- Azstarys (Drug) $207.48
- NURTEC ODT (Drug) $207.31
- FARXIGA (Drug) $201.11
- QUVIVIQ (Drug) $185.49
- REXULTI (Drug) $173.56
- XIFAXAN (Drug) $170.86
- Otezla (Drug) $162.52
- NOCDURNA (Drug) $154.74
- SINUVA (Drug) $146.61
- ELIQUIS (Drug) $141.85
- QULIPTA (Drug) $122.70
- LO LOESTRIN FE (Drug) $107.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.